Loading...
Relatlimab is a monoclonal antibody biosimilar expressed in CHO cells, targeting LAG3/CD223, Relatlimab targets LAG-3, which is a protein that not only helps increase the activity of T cells on tumors, but also makes other T cells have an inhibitory effect.
Biosimilars
Human
Monoclonal
Human
LAG3/CD223
Human
IgG4 Kappa
Unconjugated
Liquid
ELISA, WB
100 µg
1 mg
Recombinant
> 95%
Purified from cell culture supernatants by Protein A/G chromatography.
0.01 M PBS. pH 7.4.
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
No
Shipped within 7-12 working days.
Biosimilars
CAS Number 1673516-98-7
Precio a consultar
Ver másPrecio a consultar
Ver másPrecio a consultar
Ver más